advertising
Link to jump to start of content The Seattle Times Company Jobs Autos Homes Rentals NWsource Classifieds seattletimes.com
The Seattle Times Business & Technology
Traffic | Weather | Your account Movies | Restaurants | Today's events

News, analysis and perspectives from the
technology team at The Seattle Times.
Have a news tip? Follow the links below to e-mail us.

All blogs and discussions:

Go

June 27, 2007

Dendreon stock gets big jolt from partnership rumors

Posted by Angel Gonzalez at 7:03 PM

Dendreon shares jumped 10 percent Tuesday in the wake of an analyst note that portrayed the Seattle biotech company as ripe for a lucrative partnership with Big Pharma.

Needham & Co.'s annual partnership report says that the number of partnerships in the biotech industry is poised to grow, according to Marketwatch. The report's authors estimate Dendreon is likely to seek a partner from outside the U.S. to help with the marketing and development of Provenge, its prostate cancer-fighting drug.

The report "triggered the rumor mill," says David Miller, an analyst at Seattle-based Biotech Stock Research. On Tuesday, Dendreon shares closed at $7.17, up 66 cents, or 10.14 percent.

Share:    Digg     Newsvine

Tricia Duryee
Tricia Duryee
E-mail|Bio


Angel Gonzalez
Angel Gonzalez
E-mail|Bio


Kristi Heim
Kristi Heim
E-mail|Bio


Benjamin J. Romano
Benjamin J. Romano
E-mail|Bio


Mark Watanabe
Mark
Watanabe

E-mail|Bio

Marketplace

advertising

advertising